Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-004508
Filing Date
2014-01-23
Accepted
2014-01-23 12:52:39
Documents
1
Period of Report
2012-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3140
  Complete submission text file 0001209191-14-004508.txt   4544
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DURATA THERAPEUTICS, INC. 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address
Giles Lisa M. (Reporting) CIK: 0001568850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35599 | Film No.: 14542258